CoChat

Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China

Open access
Lu, Yuan, Zhang, Haibo, Lu, Jiapeng, Ding, Qinglan, Li, Xinyue, Wang, Xiaochen, Sun, Daqi, Tan, Lingyi, Mu, Lin, Liu, Jiamin, Feng, Fang, Yang, Hao, Zhao, Hongyu, Schulz, Wade L., Krumholz, Harlan M., Pan, Xiangbin, Li, Jing, China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project Collaborative Group, Huang, Chun, Dong, Zhong, Jiang, Bo, Guo, Zhigang, Zhang, Yingyi, Sun, Jixin, Liu, Yuhuan, Ren, Zeping, Meng, Yaqing, Wang, Zhifen, Xi, Yunfeng, Xing, Liying, Tian, Yuanmeng, Liu, Jianwei, Fu, Yao, Liu, Ting, Sun, Wei, Yan, Shichun, Jin, Lin, Zheng, Yang, Wang, Jing, Yan, Jing, Xu, Xiaoling, Chen, Yeji, Xing, Xiuya, Zhang, Luan, Zhong, Wenling, Fang, Xin, Zhu, Liping, Xu, Yan, Guo, Xiaolei, Xu, Chunxiao, Zhou, Gang, Fan, Lei, Qi, Minjie, Zhu, Shuzhen, Qi, Junfeng, Li, Junlin, Yin, Li, Liu, Qiong, Geng, Qingshan, Feng, Yingqing, Wang, Jiabin, Wen, Hong, Han, Xuemei, Liu, Puyu, Ding, Xianbin, Xu, Jie, Deng, Ying, He, Jun, Liu, Gui'e, Jiang, Chenxi, Zha, Shun, Yang, Cangjiang, Bai, Guoxia, Yu, Yue, Tashi, Zongji, Qiu, Lin, Hu, Zhiping, He, Hupeng, Zhang, Jing, Zhou, Minru, Li, Xiaoping, Zhao, Jianhua, Ma, Shaoning, Ma, Yitong, Huang, Ying, Zhang, Yuchen, Li, Fanka, Shen, Jiacong · 2021 · JAMA Network Open
Cited by 204

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Importance: Dyslipidemia, the prevalence of which historically has been low in China, is emerging as the second leading yet often unaddressed factor associated with the risk of cardiovascular diseases. However, recent national data on the prevalence, treatment, and control of dyslipidemia are lacking. Objective: To assess the prevalence, treatment, and control of dyslipidemia in community residents and the availability of lipid-lowering medications in primary care institutions in China. Design, Setting, and Participants: This cross-sectional study used data from the China-PEACE (Patient-Centered Evaluative Assessment of Cardiac Events) Million Persons Project, which enrolled 2 660 666 community residents aged 35 to 75 years from all 31 provinces in China between December 2014 and May 2019, and the China-PEACE primary health care survey of 3041 primary care institutions. Data analysis was performed from June 2019 to March 2021. Exposures: Study period. Main Outcomes and Measures: The main outcome was the prevalence of dyslipidemia, which was defined as total cholesterol greater than or equal to 240 mg/dL, low-density lipoprotein cholesterol (LDL-C) greater than or equal to 160 mg/dL, high-density lipoprotein cholesterol (HDL-C) less than 40 mg/dL, triglycerides greater than or equal to 200 mg/dL, or self-reported use of lipid-lowering medications, in accordance with the 2016 Chinese Adult Dyslipidemia Prevention Guideline. Results: This study included 2 314 538 participants with lipid measurements (1 389 322 women [60.0%]; mean [SD] age, 55.8 [9.8] years). Among them, 781 865 participants (33.8%) had dyslipidemia. Of 71 785 participants (3.2%) who had established atherosclerotic cardiovascular disease (ASCVD) and were recommended by guidelines for lipid-lowering medications regardless of LDL-C levels, 10 120 (14.1%) were treated. The overall control rate of LDL-C (≤70 mg/dL) among adults with established ASCVD was 26.6% (19 087 participants), with the control rate being 44.8% (4535 participants) among those who were treated and 23.6% (14 552 participants) among those not treated. Of 236 579 participants (10.2%) with high risk of ASCVD, 101 474 (42.9%) achieved LDL-C less than or equal to 100 mg/dL. Among participants with established ASCVD, advanced age (age 65-75 years, odds ratio [OR], 0.63; 95% CI, 0.56-0.70), female sex (OR, 0.56; 95% CI, 0.53-0.58), lower income (reference category), smoking (OR, 0.89; 95% CI, 0.85-0.94), alcohol consumption (OR, 0.87; 95% CI, 0.83-0.92), and not having diabetes (reference category) were associated with lower control of LDL-C. Among participants with high risk of ASCVD, younger age (reference category) and female sex (OR, 0.58; 95% CI, 0.56-0.59) were associated with lower control of LDL-C. Of 3041 primary care institutions surveyed, 1512 (49.7%) stocked statin and 584 (19.2%) stocked nonstatin lipid-lowering drugs. Village clinics in rural areas had the lowest statin availability. Conclusions and Relevance: These findings suggest that dyslipidemia has become a major public health problem in China and is often inadequately treated and uncontrolled. Statins were available in less than one-half of the primary care institutions. Strategies aimed at detection, prevention, and treatment are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamanetworkopen.2021.27573

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 204

Metadata

Authors
Lu, Y., Zhang, H., Lu, J., Ding, Q., Li, X., Wang, X., Sun, D., Tan, L., Mu, L., Liu, J., Feng, F., Yang, H., Zhao, H., Schulz, W. L., Krumholz, H. M., Pan, X., Li, J., China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project Collaborative Group, Huang, C., Dong, Z., Jiang, B., Guo, Z., Zhang, Y., Sun, J., Liu, Y., Ren, Z., Meng, Y., Wang, Z., Xi, Y., Xing, L., Tian, Y., Liu, J., Fu, Y., Liu, T., Sun, W., Yan, S., Jin, L., Zheng, Y., Wang, J., Yan, J., Xu, X., Chen, Y., Xing, X., Zhang, L., Zhong, W., Fang, X., Zhu, L., Xu, Y., Guo, X., Xu, C., Zhou, G., Fan, L., Qi, M., Zhu, S., Qi, J., Li, J., Yin, L., Liu, Q., Geng, Q., Feng, Y., Wang, J., Wen, H., Han, X., Liu, P., Ding, X., Xu, J., Deng, Y., He, J., Liu, G., Jiang, C., Zha, S., Yang, C., Bai, G., Yu, Y., Tashi, Z., Qiu, L., Hu, Z., He, H., Zhang, J., Zhou, M., Li, X., Zhao, J., Ma, S., Ma, Y., Huang, Y., Zhang, Y., Li, F., & Shen, J.
Venue
JAMA Network Open
Published
2021-09-29
Volume
4
Issue
9
Pages
e2127573
ISSN
2574-3805 (ISSN-L)
OpenAlex
W3203110973
Cited by
204
References
6
FWCI
25.84
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China. https://app.cochat.ai/papers/10.1001/jamanetworkopen.2021.27573
The paper
Lu, Y., Zhang, H., Lu, J., Ding, Q., Li, X., Wang, X., Sun, D., Tan, L., Mu, L., Liu, J., Feng, F., Yang, H., Zhao, H., Schulz, W. L., Krumholz, H. M., Pan, X., Li, J., China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project Collaborative Group, Huang, C., . . . Shen, J. (2021). Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2021.27573

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.